Article
Pathology
Julien Dagher, Angelique Brunot, Bertrand Evrard, Solene-Florence Kammerer-Jacquet, Marion Beaumont, Laurence Cornevin, Fanny Derquin, Gregory Verhoest, Karim Bensalah, Alexandra Lespagnol, Frederic Dugay, Marc-Antoine Belaud-Rotureau, Frederic Chalmel, Nathalie Rioux-Leclercq
Summary: Metastatic evolution in clear cell renal cell carcinoma is complex, with tumor heterogeneity resulting from clonal evolution playing a role in metastatic dissemination. Using an integrative multiomics strategy, it was found that all sites were heterogeneous and polyclonal, with each tumor site containing two aggressive subclonal populations.
JOURNAL OF CLINICAL PATHOLOGY
(2022)
Article
Medicine, Research & Experimental
Fabiola Lili Sarmiento-Salinas, Andrea Perez-Gonzalez, Adilene Acosta-Casique, Adrian Ix-Ballote, Alfonso Diaz, Samuel Trevino, Nora Hilda Rosas-Murrieta, Lourdes Millan-Perez-Pena, Paola Maycotte
Summary: Cancer is a major global cause of death, with the role of reactive oxygen species (ROS) in cancer development and progression being extensively studied. However, conflicting evidence exists regarding the specific impact of ROS on cancer, which may vary depending on the type of cancer and stage of tumorigenesis. Recent research has focused on exploring the diverse aspects of ROS interaction with cancer at different stages of cancer progression.
Review
Nanoscience & Nanotechnology
Yuhan Wang, Zhenyu Yin, Lei Gao, Bin Ma, Jianming Shi, Hao Chen
Summary: Metastasis to the liver, a common pattern with poor prognosis, poses challenges to conventional therapies. Poor metastatic targeting ability, systemic toxicities, and inability to modulate the tumor microenvironment are major drawbacks. Lipid nanoparticles-based strategies, such as galactosylated or active-targeting chemotherapeutics liposomes, show promise in liver metastasis management. This review summarizes the state-of-art lipid nanoparticles-based therapies, focusing on drug-encapsulated nanoparticles targeting cancer cells and the tumor microenvironment for future clinical oncology practice.
INTERNATIONAL JOURNAL OF NANOMEDICINE
(2023)
Review
Oncology
Tiuri E. Kroese, Hanneke W. M. Van Laarhoven, Magnus Nilsson, Florian Lordick, Matthias Guckenberger, Jelle P. Ruurda, Domenico D'Ugo, Karin Haustermans, Eric Van Cutsem, Richard Van Hillegersberg, Peter S. N. Van Rossum
Summary: Local treatment may improve overall survival in patients with esophagogastric cancer and oligometastatic disease (OMD). The current literature defines OMD as the presence of metastases limited to one organ with no more than three lesions and the presence of an extra-regional lymph node station. Local treatment appears to be associated with improved OS compared to systemic therapy alone.
EUROPEAN JOURNAL OF CANCER
(2022)
Article
Multidisciplinary Sciences
Fangyu Song, Wenshuo Zhang, Xiaohui Li, Xiaoqing Chen, Xuejun Yuan, Mingjin Jiang, Yunhe Zhao, Qingxin Liu, Zizhang Zhou
Summary: The main cause of high mortality in cancer patients is tumor metastasis, and exploring the underlying mechanism of tumor metastasis is important for clinical treatments. This study identifies the transcription factor Apt/FSBP as a suppressor for tumor metastasis, providing it as a potential drug target for tumor treatment.
Article
Oncology
Kelsey L. Corrigan, Alison Yoder, Brian De, Lilie Lin, Anuja Jhingran, Melissa M. Joyner, Patricia J. Eifel, Lauren E. Colbert, Karen H. Lu, Ann H. Klopp
Summary: This study aimed to evaluate the long-term survival of patients with recurrent or oligometastatic gynecological cancer (ROMGC) treated with radiation therapy (RT) and investigate their clinical characteristics. The study found that patients in the chemoradiation group had higher median disease-free survival (DFS) compared to those treated with RT alone. Further randomized studies are needed to identify the patients who would benefit the most.
GYNECOLOGIC ONCOLOGY
(2022)
Article
Oncology
Tiuri E. Kroese, Sebastian M. Christ, Peter S. N. van Rossum, Matthijs D. L. Burger, George S. Buijs, Urs Muhlematter, Nicolaus Andratschke, Jelle P. Ruurda, Martin Hullner, Christian A. Gutschow, Richard van Hillegersberg, Matthias Guckenberger
Summary: This multicenter study assessed the incidence and survival of patients with esophagogastric cancer and oligometastatic disease (OMD) in two tertiary referral cancer centers in The Netherlands and Switzerland. The study found that local treatment plus systemic therapy was associated with improved overall survival compared to systemic therapy alone.
RADIOTHERAPY AND ONCOLOGY
(2022)
Article
Oncology
Lucas W. Thornblade, Ernest Han, Yuman Fong
Summary: Patients with colorectal cancer ovarian metastasis have favorable long-term survival. Survival rates are higher if the tumor is isolated to the ovary or if metachronous to the primary cancer.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2021)
Article
Urology & Nephrology
Jack R. Andrews, Mohamed E. Ahmed, Vidit Sharma, Cameron Britton, Bradley Stish, Ryan Phillips, A. Tuba Kendi, Vidhu B. Joshi, Akshay Sood, Mathew K. Tollefson, Stephen A. Boorjian, R. Jeffery Karnes, Eugene D. Kwon
Summary: This study characterizes the outcomes of metastasis-directed therapy without concurrent androgen deprivation therapy in patients with solitary metastatic lesions in prostate cancer. The results demonstrate that this approach can delay the initiation of systemic therapy and call for further prospective studies in patients with solitary recurrent prostate cancer metastases.
JOURNAL OF UROLOGY
(2022)
Article
Urology & Nephrology
Nicholas H. Chakiryan, Aaron Dahmen, Marco Bandini, Filippo Pederzoli, Laura Marandino, Maarten Albersen, Eduard Roussel, Yao Zhu, Ding-Wei Ye, Antonio A. Ornellas, Mario Catanzaro, Oliver W. Hakenberg, Axel Heidenreich, Friederike Haidl, Nick Watkin, Michael Ager, Jad Chahoud, Alberto Briganti, Roberto Salvioni, Francesco Montorsi, Andrea Necchi, Philippe E. Spiess
Summary: This study found that 31.9% of pSCC patients experienced post-ILND recurrence, which was associated with high pN staging. Over 95% of distant, inguinal, and pelvic recurrences occurred within 48 months post-ILND. Local recurrences occurred over a longer timeline, highlighting the necessity of long-term surveillance of the primary site.
JOURNAL OF UROLOGY
(2021)
Article
Agriculture, Multidisciplinary
Shengtao Yang, Zhenbang Xiao, Liyuan Lin, Yanfei Tang, Pengzhi Hong, Shengli Sun, Chunxia Zhou, Zhong-Ji Qian
Summary: The study reveals that DIF can inhibit tumor metastasis and angiogenesis by regulating multiple signaling pathways, and it has inhibitory effects on the production of VEGF and PDGF.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
(2021)
Article
Urology & Nephrology
Kenneth J. Pienta, Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frederic Pouliot, Stephan Probst, Lawrence Saperstein, Mark A. Preston, Ajjai S. Alva, Akash Patnaik, Jeremy C. Durack, Nancy Stambler, Tess Lin, Jessica Jensen, Vivien Wong, Barry A. Siegel, Michael J. Morris
Summary: The study aimed to evaluate the diagnostic performance of F-18-DCFPyL positron emission tomography/computerized tomography in detecting metastatic sites of prostate cancer. The results showed high specificity and positive predictive value, but moderate sensitivity.
JOURNAL OF UROLOGY
(2021)
Article
Oncology
Zhenyu Yang, Xingliang Tan, Yanjun Wang, Yuantao Zou, Dong Chen, Zhiming Wu, Zhuowei Liu, Yonghong Li, Zike Qin, Hui Han, Fangjian Zhou, Kai Yao
Summary: The study evaluated the relationship between deep inguinal lymph node metastasis and pelvic lymph node metastasis in PSCC, finding that deep ILNM is the most accurate factor for predicting PLNM. Patients with deep ILNM should be referred for pelvic lymph node dissection, as it indicates poor prognosis.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Catherine T. Haring, Lulia A. Kana, Sarah M. Dermody, Collin Brummel, Jonathan B. McHugh, Keith A. Casper, Steven B. Chinn, Kelly M. Malloy, Michelle Mierzwa, Mark E. P. Prince, Andrew J. Rosko, Jennifer Shah, Chaz L. Stucken, Andrew G. Shuman, J. Chad Brenner, Matthew E. Spector, Francis P. Worden, Paul L. Swiecicki
Summary: A retrospective analysis of 447 patients with HNSCC revealed that HPV negativity, high neutrophil/lymphocyte ratio, disease-free interval ≤6 months, and poor performance status were predictors of worse survival. Furthermore, the majority of recurrences and metastases occurred within 6 months to 2 years after treatment completion.
Review
Oncology
Vincent Vandecaveye, Frederic Amant, Frederic Lecouvet, Kristel Van Calsteren, Raphaela Carmen Dresen
Summary: Cancer diagnosis during pregnancy presents challenges, with physiological changes making imaging interpretation difficult. Ultrasound and MRI are preferred imaging modalities for pregnant women, while CT and nuclear imaging should only be used when the maternal benefit outweighs fetal risk.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2021)